Received May 6, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HIBV | HIB (ACTHIB) | SANOFI PASTEUR | UNK | UK433AD | IM / LL |
gave the ACT-HIB vaccine with a diluent from a Merck vaccine,with no reported adverse event; Initial information regarding this unsolicited valid non-serious case, was received on 20-Apr-2026 from via nurse (healthcare professional). This case involves a 6-month-old female patient to whom the haemophilus type B (HIB) vaccine (ACT-HIB) was given with a diluent from a Merck vaccine, with no reported adverse event. The patient's past medical history, past drugs, and family history were not provided. Concomitant medication(s) included diphtheria vaccine toxoid, hepatitis B vaccine rHBsAg (yeast), pertussis vaccine acellular 3-component, polio vaccine inactivated 3 valent (Vero), tetanus vaccine toxoid (Pediarix), pneumococcal vaccine conjugate 20 valent (CRM197) (Pfizer PCV 20), and influenza vaccine (GSK Flu vaccine). On 17-Apr-2026, the patient received haemophilus type B (HIB) vaccine Powder and solvent for solution for injection dose 1 Strength = standard dose 0.5 ml 1x(once) intramuscularly in left thigh for immunization, vaccine was given with a diluent from a Merck vaccine, with no reported adverse event [(Product preparation issue, and latency: same day) (batch: UK433AD, expiry: 31-Aug-2027)]. Action taken: Not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Comments: NONE
Dtap hepb; Prevnar 20; Influenza vaccine